[
  {
    "ts": "2025-11-28T13:35:00+00:00",
    "headline": "Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now?",
    "summary": "GILD's HIV strength, new approvals, and rising estimates set it apart as it edges past a challenged rival in growth prospects.",
    "url": "https://finance.yahoo.com/news/bristol-myers-vs-gilead-sciences-133500245.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "49f56c52-825b-3c51-b0f6-bf74ff4afc4c",
      "content": {
        "id": "49f56c52-825b-3c51-b0f6-bf74ff4afc4c",
        "contentType": "STORY",
        "title": "Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now?",
        "description": "",
        "summary": "GILD's HIV strength, new approvals, and rising estimates set it apart as it edges past a challenged rival in growth prospects.",
        "pubDate": "2025-11-28T13:35:00Z",
        "displayTime": "2025-11-28T13:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/a85eb7319e956e8beb6c9c5b0aadb1b7",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NuaC8R_wAbhCY5KPvmp9LA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a85eb7319e956e8beb6c9c5b0aadb1b7.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cLIW4zpH3bXqWfT.Oe9Uew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a85eb7319e956e8beb6c9c5b0aadb1b7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-vs-gilead-sciences-133500245.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-vs-gilead-sciences-133500245.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-28T22:31:04+00:00",
    "headline": "Is Gilead Sciences a Bargain After 40% Share Price Surge and Pipeline Updates?",
    "summary": "Ever wondered if Gilead Sciences might be trading for less than it's worth? Let’s dig into its recent moves to see if there's a value opportunity hiding in plain sight. Gilead Sciences' stock has been on the rise, climbing 6.2% over the past month and surging 37.0% year-to-date, for a strong 40.0% jump over the last year. Healthcare headlines have been buzzing, with recent positive developments around Gilead’s pipeline treatments and strategic partnerships attracting fresh attention from...",
    "url": "https://finance.yahoo.com/news/gilead-sciences-bargain-40-share-223104203.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "386e14e2-5877-3753-9465-01b1d04df93f",
      "content": {
        "id": "386e14e2-5877-3753-9465-01b1d04df93f",
        "contentType": "STORY",
        "title": "Is Gilead Sciences a Bargain After 40% Share Price Surge and Pipeline Updates?",
        "description": "",
        "summary": "Ever wondered if Gilead Sciences might be trading for less than it's worth? Let’s dig into its recent moves to see if there's a value opportunity hiding in plain sight. Gilead Sciences' stock has been on the rise, climbing 6.2% over the past month and surging 37.0% year-to-date, for a strong 40.0% jump over the last year. Healthcare headlines have been buzzing, with recent positive developments around Gilead’s pipeline treatments and strategic partnerships attracting fresh attention from...",
        "pubDate": "2025-11-28T22:31:04Z",
        "displayTime": "2025-11-28T22:31:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HAEiJmFsYXJTRBPxnneP6w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hXB9F2qU7k4qk3_k1DQd9A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-bargain-40-share-223104203.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-bargain-40-share-223104203.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]